Showing results (1-10 of 2,325) with videos related to

Sort By:
Pageof 233
Acta Crystallographica. Section C, Crystal Structure Communications|September 14, 1999
Alpha-cyano-N-(2,5-dibromophenyl)-beta-hydroxybut-2-enamideS Ghosh, F M Uckun
Current Cancer Drug Targets|August 22, 2002
Rational design of potent and selective EGFR tyrosine kinase inhibitors as anticancer agentsS Ghosh, X P Liu, Y Zheng, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|October 12, 2000
Three leflunomide metabolite analogsS Ghosh, J D Jennissen, Y Zheng, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|February 15, 2001
4-[3-Bromo-4-hydroxyphenyl)amino]-6,7-dimethoxyquinazolin-1-ium chloride methanol solvate and 4-[(3-hydroxyphenyl)amino]-6,7-dimethoxy-1-quinazolinium chlorideS Ghosh, J D Jennissen, X P Liu, et al.
Journal of Inorganic Biochemistry|May 26, 2001
X-ray structure, solution properties, and biological activity profile of vanadocene(IV) acetylacetonate complex,P Ghosh, S Ghosh, C Navara, et al.
Current Pharmaceutical Design|September 20, 2001
Rationally designed anti-mitotic agents with pro-apoptotic activityF M Uckun
Biochemical Pharmacology|September 29, 1998
Bruton's tyrosine kinase (BTK) as a dual-function regulator of apoptosisF M Uckun
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Specificity of alpha-cyano-beta-hydroxy-beta-methyl-n-[4-(trifluoromethoxy)phe nyl]-propenamide as an inhibitor of the epidermal growth factor receptor tyrosine kinaseS Ghosh, Y Zheng, X Jun, et al.
Pageof 233